Results 111 to 120 of about 89,071 (292)

Biomarkers in heart failure: Traditional and emerging indicators for prognosis

open access: yes
ESC Heart Failure, EarlyView.
Arnold Péter Ráduly   +4 more
wiley   +1 more source

Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus

open access: yesESC Heart Failure, EarlyView.
The HFFS is a new multidimensional tool for the identification of frailty in patients with HF developed through a Delphi process involving 54 international experts in the management of HF and frailty. Two versions of the HFFS have been developed after the third round of the Delphi process.
Cristiana Vitale   +60 more
wiley   +1 more source

Up‐titration of medication in patients with new‐onset heart failure with and without atrial fibrillation

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Differences in guideline‐directed medical therapy (GDMT) and clinical outcomes have been observed between heart failure (HF) patients with atrial fibrillation (AF) versus those in sinus rhythm. This study evaluated the effects of up‐titration of HF therapies, consisting of beta‐blockers, angiotensin‐converting‐enzyme inhibitors (ACEis ...
Arietje J.L. Zandijk   +6 more
wiley   +1 more source

Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Cardiac resynchronization therapy (CRT) is guideline recommended for the treatment of symptomatic heart failure (HF) with reduced left ventricular ejection fraction and prolonged QRS. However, patients with common comorbidities, such as persistent/permanent atrial fibrillation (AF), are often under‐represented in clinical trials.
Ignacio García‐Bolao   +17 more
wiley   +1 more source

Comparative safety and effectiveness of angiotensin converting enzyme inhibitors and thiazides and thiazide‐like diuretics under strict monotherapy

open access: yesThe Journal of Clinical Hypertension
Previous work comparing safety and effectiveness outcomes for new initiators of angiotensin converting‐enzyme inhibitors (ACEi) and thiazides demonstrated more favorable outcomes for thiazides, although cohort definitions allowed for addition of a second
Tara V. Anand   +4 more
doaj   +1 more source

Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA‐HF)

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The interstitial space is the major compartment in which the excess fluid is located, forming peripheral congestion in acute decompensated heart failure (ADHF). The lymphatic system is responsible for the constant drainage of the compartment.
Jan Biegus   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy